Human Gene CD3G (ENST00000532917.3) from GENCODE V44
Description: Homo sapiens CD3g molecule (CD3G), mRNA. (from RefSeq NM_000073) RefSeq Summary (NM_000073): The protein encoded by this gene is the CD3-gamma polypeptide, which together with CD3-epsilon, -delta and -zeta, and the T-cell receptor alpha/beta and gamma/delta heterodimers, forms the T-cell receptor-CD3 complex. This complex plays an important role in coupling antigen recognition to several intracellular signal-transduction pathways. The genes encoding the epsilon, gamma and delta polypeptides are located in the same cluster on chromosome 11. Defects in this gene are associated with T cell immunodeficiency. [provided by RefSeq, Jul 2008]. Gencode Transcript: ENST00000532917.3 Gencode Gene: ENSG00000160654.11 Transcript (Including UTRs) Position: hg38 chr11:118,344,344-118,355,161 Size: 10,818 Total Exon Count: 7 Strand: + Coding Region Position: hg38 chr11:118,344,424-118,352,469 Size: 8,046 Coding Exon Count: 6
ID:CD3G_HUMAN DESCRIPTION: RecName: Full=T-cell surface glycoprotein CD3 gamma chain; AltName: Full=T-cell receptor T3 gamma chain; AltName: CD_antigen=CD3g; Flags: Precursor; FUNCTION: The CD3 complex mediates signal transduction. SUBUNIT: The TCR/CD3 complex of T-lymphocytes consists of either a TCR alpha/beta or TCR gamma/delta heterodimer coexpressed at the cell surface with the invariant subunits of CD3 labeled gamma, delta, epsilon, zeta, and eta. SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein. DOMAIN: A di-leucine motif and a tyrosine-based motif are individually sufficient to induce both endocytosis and delivery to lysosomes. SIMILARITY: Contains 1 Ig-like (immunoglobulin-like) domain. SIMILARITY: Contains 1 ITAM domain. WEB RESOURCE: Name=CD3Gbase; Note=CD3G mutation db; URL="http://bioinf.uta.fi/CD3Gbase/"; WEB RESOURCE: Name=Wikipedia; Note=CD3 receptor entry; URL="http://en.wikipedia.org/wiki/CD3_receptor";
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on P09693
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Gene Ontology (GO) Annotations with Structured Vocabulary
Molecular Function: GO:0004888 transmembrane signaling receptor activity GO:0030159 receptor signaling complex scaffold activity GO:0042608 T cell receptor binding GO:0042803 protein homodimerization activity GO:0046982 protein heterodimerization activity
Biological Process: GO:0002250 adaptive immune response GO:0002376 immune system process GO:0007163 establishment or maintenance of cell polarity GO:0007166 cell surface receptor signaling pathway GO:0015031 protein transport GO:0038096 Fc-gamma receptor signaling pathway involved in phagocytosis GO:0042110 T cell activation GO:0050776 regulation of immune response GO:0050852 T cell receptor signaling pathway GO:0051260 protein homooligomerization GO:0061024 membrane organization GO:0065003 macromolecular complex assembly GO:0070228 regulation of lymphocyte apoptotic process
Cellular Component: GO:0005886 plasma membrane GO:0005887 integral component of plasma membrane GO:0016020 membrane GO:0016021 integral component of membrane GO:0030665 clathrin-coated vesicle membrane GO:0042101 T cell receptor complex GO:0042105 alpha-beta T cell receptor complex
Descriptions from all associated GenBank mRNAs
AK299997 - Homo sapiens cDNA FLJ51080 complete cds, moderately similar to T-cell surface glycoprotein CD3 gamma chain precursor. AK313966 - Homo sapiens cDNA, FLJ94613, Homo sapiens CD3G antigen, gamma polypeptide (TiT3 complex) (CD3G),mRNA. JD470112 - Sequence 451136 from Patent EP1572962. AK315895 - Homo sapiens cDNA, FLJ79544 complete cds, highly similar to T-cell surface glycoprotein CD3 gamma chainprecursor. AK310622 - Homo sapiens cDNA, FLJ17664. X60492 - Human mRNA for CD3-gamma, with 17 bp deletion associated with T-cell receptor immunodeficiency. BC069685 - Homo sapiens cDNA clone IMAGE:7262517, containing frame-shift errors. X04145 - Human mRNA for T-cell receptor T3 gamma polypeptide. AK223314 - Homo sapiens mRNA for CD3G gamma precursor variant, clone: TMS06008. AK310578 - Homo sapiens cDNA, FLJ17620. JD141202 - Sequence 122226 from Patent EP1572962. BC113830 - Homo sapiens CD3g molecule, gamma (CD3-TCR complex), mRNA (cDNA clone MGC:138597 IMAGE:40029587), complete cds. KJ890851 - Synthetic construct Homo sapiens clone ccsbBroadEn_00245 CD3G gene, encodes complete protein. JD311122 - Sequence 292146 from Patent EP1572962. JD147485 - Sequence 128509 from Patent EP1572962. JD176036 - Sequence 157060 from Patent EP1572962. JD431876 - Sequence 412900 from Patent EP1572962. JD254674 - Sequence 235698 from Patent EP1572962. MA869004 - JP 2018536436-A/840: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869005 - JP 2018536436-A/841: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869006 - JP 2018536436-A/842: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869007 - JP 2018536436-A/843: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869008 - JP 2018536436-A/844: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869009 - JP 2018536436-A/845: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869010 - JP 2018536436-A/846: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869011 - JP 2018536436-A/847: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869012 - JP 2018536436-A/848: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869013 - JP 2018536436-A/849: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869014 - JP 2018536436-A/850: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869015 - JP 2018536436-A/851: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869016 - JP 2018536436-A/852: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869017 - JP 2018536436-A/853: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869018 - JP 2018536436-A/854: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869033 - JP 2018536436-A/869: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869034 - JP 2018536436-A/870: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869035 - JP 2018536436-A/871: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869039 - JP 2018536436-A/875: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA878205 - JP 2018536436-A/10041: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869040 - JP 2018536436-A/876: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA878204 - JP 2018536436-A/10040: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869041 - JP 2018536436-A/877: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869042 - JP 2018536436-A/878: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869043 - JP 2018536436-A/879: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869044 - JP 2018536436-A/880: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869045 - JP 2018536436-A/881: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869049 - JP 2018536436-A/885: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869050 - JP 2018536436-A/886: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869051 - JP 2018536436-A/887: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA878198 - JP 2018536436-A/10034: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869052 - JP 2018536436-A/888: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA878196 - JP 2018536436-A/10032: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869063 - JP 2018536436-A/899: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869064 - JP 2018536436-A/900: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869065 - JP 2018536436-A/901: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869066 - JP 2018536436-A/902: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA878200 - JP 2018536436-A/10036: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869067 - JP 2018536436-A/903: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA878201 - JP 2018536436-A/10037: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869068 - JP 2018536436-A/904: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869069 - JP 2018536436-A/905: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA878197 - JP 2018536436-A/10033: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869070 - JP 2018536436-A/906: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869078 - JP 2018536436-A/914: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869079 - JP 2018536436-A/915: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869080 - JP 2018536436-A/916: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869081 - JP 2018536436-A/917: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869087 - JP 2018536436-A/923: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869088 - JP 2018536436-A/924: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869089 - JP 2018536436-A/925: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869090 - JP 2018536436-A/926: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869091 - JP 2018536436-A/927: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869092 - JP 2018536436-A/928: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869093 - JP 2018536436-A/929: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869104 - JP 2018536436-A/940: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869105 - JP 2018536436-A/941: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869106 - JP 2018536436-A/942: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869107 - JP 2018536436-A/943: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869108 - JP 2018536436-A/944: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869109 - JP 2018536436-A/945: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869110 - JP 2018536436-A/946: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869111 - JP 2018536436-A/947: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869112 - JP 2018536436-A/948: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869113 - JP 2018536436-A/949: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869114 - JP 2018536436-A/950: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MA869115 - JP 2018536436-A/951: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. MP231162 - Sequence 186 from Patent EP3512950. LY600617 - KR 1020180133840-A/10779: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY600616 - KR 1020180133840-A/10778: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY600610 - KR 1020180133840-A/10772: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY600608 - KR 1020180133840-A/10770: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY600612 - KR 1020180133840-A/10774: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY600613 - KR 1020180133840-A/10775: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY600609 - KR 1020180133840-A/10771: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591416 - KR 1020180133840-A/840: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591417 - KR 1020180133840-A/841: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591418 - KR 1020180133840-A/842: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591419 - KR 1020180133840-A/843: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591420 - KR 1020180133840-A/844: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591421 - KR 1020180133840-A/845: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591422 - KR 1020180133840-A/846: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591423 - KR 1020180133840-A/847: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591424 - KR 1020180133840-A/848: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591425 - KR 1020180133840-A/849: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591426 - KR 1020180133840-A/850: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591427 - KR 1020180133840-A/851: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591428 - KR 1020180133840-A/852: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591429 - KR 1020180133840-A/853: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591430 - KR 1020180133840-A/854: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591445 - KR 1020180133840-A/869: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591446 - KR 1020180133840-A/870: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591447 - KR 1020180133840-A/871: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591451 - KR 1020180133840-A/875: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591452 - KR 1020180133840-A/876: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591453 - KR 1020180133840-A/877: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591454 - KR 1020180133840-A/878: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591455 - KR 1020180133840-A/879: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591456 - KR 1020180133840-A/880: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591457 - KR 1020180133840-A/881: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591461 - KR 1020180133840-A/885: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591462 - KR 1020180133840-A/886: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591463 - KR 1020180133840-A/887: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591464 - KR 1020180133840-A/888: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591475 - KR 1020180133840-A/899: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591476 - KR 1020180133840-A/900: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591477 - KR 1020180133840-A/901: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591478 - KR 1020180133840-A/902: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591479 - KR 1020180133840-A/903: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591480 - KR 1020180133840-A/904: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591481 - KR 1020180133840-A/905: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591482 - KR 1020180133840-A/906: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591490 - KR 1020180133840-A/914: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591491 - KR 1020180133840-A/915: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591492 - KR 1020180133840-A/916: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591493 - KR 1020180133840-A/917: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591499 - KR 1020180133840-A/923: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591500 - KR 1020180133840-A/924: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591501 - KR 1020180133840-A/925: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591502 - KR 1020180133840-A/926: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591503 - KR 1020180133840-A/927: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591504 - KR 1020180133840-A/928: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591505 - KR 1020180133840-A/929: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591516 - KR 1020180133840-A/940: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591517 - KR 1020180133840-A/941: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591518 - KR 1020180133840-A/942: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591519 - KR 1020180133840-A/943: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591520 - KR 1020180133840-A/944: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591521 - KR 1020180133840-A/945: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591522 - KR 1020180133840-A/946: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591523 - KR 1020180133840-A/947: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591524 - KR 1020180133840-A/948: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591525 - KR 1020180133840-A/949: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591526 - KR 1020180133840-A/950: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY. LY591527 - KR 1020180133840-A/951: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
Biochemical and Signaling Pathways
KEGG - Kyoto Encyclopedia of Genes and Genomes hsa04640 - Hematopoietic cell lineage hsa04660 - T cell receptor signaling pathway hsa05142 - Chagas disease
BioCarta from NCI Cancer Genome Anatomy Project h_tcrPathway - T Cell Receptor Signaling Pathway h_tob1Pathway - Role of Tob in T-cell activation h_thelperPathway - T Helper Cell Surface Molecules h_CSKPathway - Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor h_ctla4Pathway - The Co-Stimulatory Signal During T-cell Activation h_ctlPathway - CTL mediated immune response against target cells h_tcytotoxicPathway - T Cytotoxic Cell Surface Molecules h_tcraPathway - Lck and Fyn tyrosine kinases in initiation of TCR Activation h_tcapoptosisPathway - HIV Induced T Cell Apoptosis h_stathminPathway - Stathmin and breast cancer resistance to antimicrotubule agents h_IL12Pathway - IL12 and Stat4 Dependent Signaling Pathway in Th1 Development h_no2il12Pathway - NO2-dependent IL 12 Pathway in NK cells h_il17Pathway - IL 17 Signaling Pathway h_tcrmolecule - T Cell Receptor and CD3 Complex
Reactome (by CSHL, EBI, and GO)
Protein P09693 (Reactome details) participates in the following event(s):
R-HSA-8850326 TCR binds self-lipid-based antigen via CD1 R-HSA-8850356 TCR binds microbial lipid-based antigen via CD1 R-HSA-2029455 Cross-linking of FCGRIA with IgG-coated Ag R-HSA-8866277 AP-2 directly binds some endocytic cargo R-HSA-198955 TCR complex interacts with peptide antigen-presenting MHC Class I R-HSA-202214 Dephosphorylation of Lck-pY505 by CD45 R-HSA-202233 Inactivation of Lck by Csk R-HSA-202291 Activation of Lck R-HSA-8852200 Inactivation of LCK by PTPN22 R-HSA-202165 Phosphorylation of ITAM motifs in CD3 complexes R-HSA-2029457 Cross-linking of FCGRIIIA with IgG-coated Ag R-HSA-202344 Recruitment of ZAP-70 to phosphorylated ITAMs R-HSA-389758 Dephosphorylation of CD3-zeta by PD-1 bound phosphatases R-HSA-202168 Phosphorylation of ZAP-70 by Lck R-HSA-202307 Change of PKC theta conformation R-HSA-8867756 CLASP proteins and cargo are recruited to the nascent clathrin-coated pit R-HSA-202174 Activation of ZAP-70 R-HSA-8855381 PTPN22 dephosphorylates ZAP70 R-HSA-2029452 Recruitment of SYK to phosphorylated ITAMs R-HSA-8868071 Clathrin recruits PIK3C2A R-HSA-8868661 Dynamin-mediated GTP hydrolysis promotes vesicle scission R-HSA-8868648 SYNJ hydrolyze PI(4,5)P2 to PI(4)P R-HSA-202216 Phosphorylation of SLP-76 R-HSA-202245 Phosphorylation of TBSMs in LAT R-HSA-2029449 Phosphorylation of SYK by Src kinases R-HSA-2029270 Recruitment of PLCgamma to membrane R-HSA-2029273 PI3K binds to p-6Y-SYK R-HSA-2029458 Recruitment of VAV1 to p-6Y-SYK R-HSA-2197697 Recruitment of CRKII:DOCK180:ELMO complex to FCGR R-HSA-2029272 Release of PLCG from FCGR R-HSA-8871194 RAB5 and GAPVD1 bind AP-2 R-HSA-8868658 HSPA8-mediated ATP hydrolysis promotes vesicle uncoating R-HSA-8868659 Clathrin recruits auxilins to the clathrin-coated vesicle R-HSA-8868660 Auxilin recruits HSPA8:ATP to the clathrin-coated vesicle R-HSA-8867754 F- and N- BAR domain proteins bind the clathrin-coated pit R-HSA-8868230 SNX9 recruits components of the actin polymerizing machinery R-HSA-202248 Phosphorylation of PLC-gamma1 R-HSA-2029453 Phosphorylation of VAV R-HSA-2029268 Phosphorylation and activation of PLCG R-HSA-8868072 Clathrin-associated PIK3C2A phosphorylates PI(4)P to PI(3,4)P2 R-HSA-8868236 BAR domain proteins recruit dynamin R-HSA-2029467 Activation of RAC1 by CRKII:DOCK180:ELMO R-HSA-2029451 Activation of RAC1 by VAV R-HSA-2029271 PI3K phosphorylates PIP2 to PIP3 R-HSA-8868651 Endophilins recruit synaptojanins to the clathrin-coated pit R-HSA-198933 Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell R-HSA-2029481 FCGR activation R-HSA-8856825 Cargo recognition for clathrin-mediated endocytosis R-HSA-202427 Phosphorylation of CD3 and TCR zeta chains R-HSA-1280218 Adaptive Immune System R-HSA-2029480 Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-8856828 Clathrin-mediated endocytosis R-HSA-202430 Translocation of ZAP-70 to Immunological synapse R-HSA-389948 PD-1 signaling R-HSA-202403 TCR signaling R-HSA-202424 Downstream TCR signaling R-HSA-168256 Immune System R-HSA-168249 Innate Immune System R-HSA-199991 Membrane Trafficking R-HSA-388841 Costimulation by the CD28 family R-HSA-2029482 Regulation of actin dynamics for phagocytic cup formation R-HSA-5653656 Vesicle-mediated transport R-HSA-202433 Generation of second messenger molecules R-HSA-2029485 Role of phospholipids in phagocytosis
US Server
